- Report
- March 2025
- 190 Pages
Global
From €3238EUR$3,545USD£2,762GBP
€3598EUR$3,939USD£3,068GBP
- Report
- October 2024
- 130 Pages
Global
From €5435EUR$5,950USD£4,635GBP
- Report
- April 2025
- 200 Pages
Global
From €4102EUR$4,490USD£3,498GBP
- Report
- May 2025
- 361 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- April 2025
- 175 Pages
Global
From €4102EUR$4,490USD£3,498GBP
- Report
- May 2024
- 140 Pages
Global
From €3608EUR$3,950USD£3,077GBP
- Report
- May 2024
- 134 Pages
Global
From €5937EUR$6,499USD£5,063GBP
- Report
- November 2021
- 120 Pages
Global
From €2284EUR$2,500USD£1,947GBP
- Report
- March 2024
- 200 Pages
Global
From €3791EUR$4,150USD£3,233GBP
- Report
- October 2023
- 83 Pages
Global
From €3500EUR$4,104USD£3,089GBP
The Electroretinograph (ERG) is a medical imaging technique used to measure the electrical activity of the retina. It is used to diagnose and monitor a variety of retinal diseases, such as retinitis pigmentosa, macular degeneration, and diabetic retinopathy. The ERG is also used to assess the effects of certain drugs on the retina. The procedure involves placing electrodes on the surface of the eye and measuring the electrical activity of the retina in response to light stimulation.
The ERG market is a rapidly growing segment of the medical imaging industry. It is driven by the increasing prevalence of retinal diseases, the development of new technologies, and the growing demand for non-invasive diagnostic techniques. The market is expected to continue to grow in the coming years, as new technologies are developed and the demand for non-invasive diagnostic techniques increases.
Some of the major companies in the Electroretinograph market include Nidek, Topcon, Canon, Heidelberg Engineering, and Optos. Show Less Read more